What Counts as Manufacture of Pharmaceuticals in Rev. 5?

In ISIC Rev. 5, published by the UN Statistics Division, pharmaceutical manufacturing covers producing basic pharmaceutical products and pharmaceutical preparations. That includes active pharmaceutical ingredients, medicines for human and veterinary use, and related medicinal preparations. Research into new medicines, wholesale of medicines, and dispensing by pharmacies are separate activities.

What are the two stages of pharmaceutical manufacturing?

Active ingredient production is the first stage. It creates the substances that give a medicine its effect, through synthesis or other production processes that yield a specific active substance. Finished preparation making is the second stage. It turns those ingredients into tablets, injections, creams, and other dosage forms, combining the active substance with other materials, forming it into a usable medicine, and packing it for distribution. A plant synthesising an active ingredient illustrates basic pharmaceutical production, while a plant formulating that ingredient into tablets and packing them illustrates pharmaceutical preparations, and the two stages differ even when they sit in the same company.

The scope here is medicines for human and veterinary use, together with related medicinal preparations, under controlled production. Quality control and regulated production are integral to pharmaceutical making, though regulation itself is not the classification test. In other words, the presence of strict controls does not by itself place work in this heading, and their absence does not remove it. The test is the production work: whether the plant makes active substances or finished medicinal preparations, as described in ISIC Rev. 5, published by the UN Statistics Division.

Which nearby activities are not pharmaceutical manufacturing?

Research into new medicines is a separate activity. A laboratory discovering or testing a potential medicine is doing research, not manufacturing a medicine for distribution, even if its work later leads to a manufactured product. Wholesale of medicines is also separate, because wholesalers distribute medicines made elsewhere rather than making them. Dispensing by pharmacies is separate again, because a pharmacy supplies a medicine to a patient rather than producing it. Each of those activities matters to health care, but none of them is the production work this heading describes.

The same care applies to ingredients that sit in chemical headings. Some pharmaceutical ingredients are produced under chemical headings rather than pharmaceutical headings, depending on the full UNSD description, and a reader should check that description rather than assuming every ingredient plant belongs here. The heading is defined by its descriptions, not by the word medicine appearing somewhere in a business description. A plant making a substance that later becomes a medicine may still belong in chemicals if that is where its production description sits.

How should a pharmaceutical heading be checked?

Checking is part of using a classification well. The UNSD sources in the frontmatter give the international reference for ISIC Rev. 5, published by the UN Statistics Division, while national institutes give the local application. A reader who checks both sources, notes the revision, and compares descriptions rather than titles will usually find the right area to investigate further. Pay particular attention to whether the work is active ingredient production or finished preparation making, because that split is the main internal boundary in this heading.

Where doubt remains, that doubt should be recorded and taken to the record holder, rather than resolved by guessing. This guide does not determine any reader’s code, principal activity, or registration. A guessed pharmaceutical heading can carry consequences beyond statistics, because it may be read alongside regulatory records, and a heading that looks plausible but was never checked is a poor basis for any formal use. The record holder, not this guide, confirms an entry.

Why does this guide refuse to judge safety or approval?

This guide is statistical only. It does not assess safety, efficacy, or approval of any medicine, which are matters for medicines regulators in each country. A medicine can be manufactured under this heading and still need regulatory approval before it can be sold, and a medicine can be approved in one country and not in another while its manufacturing description stays the same. Mixing the statistical question with the regulatory question would confuse two different authorities and two different kinds of decision.

The statistical heading asks what production work was done. The regulator asks whether the resulting medicine is safe, effective, and permitted for sale. Both questions matter, but they are answered from different evidence and by different bodies. Readers who need both answers should pursue both routes, and should not treat a statistical description as evidence about approval, or an approval decision as evidence about a statistical heading.

Readers considering a pharmaceutical activity should take this guide as background information only. It does not settle any reader’s code, principal activity, or registration, and it does not judge any medicine. Compare the active ingredient or preparation work with the UNSD Rev. 5 descriptions, and confirm any formal entry with the national statistical institute or business register that holds the record.